ChemicalBook >> CAS DataBase List >>SLC13A5-IN-1

SLC13A5-IN-1

CAS No.
2227548-95-8
Chemical Name:
SLC13A5-IN-1
Synonyms
SLC13A5-IN-1;SLC13A5-IN-1, 10 mM in DMSO;N-(4-Chlorobenzyl)-1-((3,5-dichlorophenyl)sulfonyl)piperidine-4-carboxamide;N-[(4-chlorophenyl)methyl]-1-(3,5-dichlorobenzen esulfonyl)piperidine-4-carboxamide;4-Piperidinecarboxamide, N-[(4-chlorophenyl)methyl]-1-[(3,5-dichlorophenyl)sulfonyl]-;hSLC3A5,metabolic,SLC-13A5-IN-1,SLC13A5IN1,Inhibitor,Citrate,SLC13A5,cardiovascular,inhibit,disease,Sodium Channel,Uptake,Na channels,Na+ channels,SLC13A5 IN 1
CBNumber:
CB55855431
Molecular Formula:
C19H19Cl3N2O3S
Molecular Weight:
461.79
MDL Number:
MFCD32671334
MOL File:
2227548-95-8.mol
MSDS File:
SDS
Last updated:2026-09-10 08:17:50

SLC13A5-IN-1 Properties

Density 1.436±0.06 g/cm3(Predicted)
storage temp. Store at -20°C
solubility DMSO: 7 mg/mL (15.16 mM);Ethanol: Insoluble
pka 14.79±0.20(Predicted)
form Solid
color White to off-white
Water Solubility Water: Insoluble

SLC13A5-IN-1 price

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
ChemScene CS-0103855 SLC13A5-IN-1 98.62% 2227548-95-8 5mg $135 2026-06-04 Buy
ChemScene CS-0103855 SLC13A5-IN-1 98.62% 2227548-95-8 10mg $217 2026-06-04 Buy
ChemScene CS-0103855 SLC13A5-IN-1 98.62% 2227548-95-8 25mg $406 2026-06-04 Buy
ChemScene CS-0103855 SLC13A5-IN-1 98.62% 2227548-95-8 50mg $650 2026-06-04 Buy
aablocks AA025OWQ N-(4-Chlorobenzyl)-1-((3,5-dichlorophenyl)sulfonyl)piperidine-4-carboxamide ≥98% 2227548-95-8 1mg $40 2026-06-02 Buy
Product number Packaging Price Buy
CS-0103855 5mg $135 Buy
CS-0103855 10mg $217 Buy
CS-0103855 25mg $406 Buy
CS-0103855 50mg $650 Buy
AA025OWQ 1mg $40 Buy

SLC13A5-IN-1 Chemical Properties, Uses, Production

Uses

SLC13A5-IN-1 is a selective sodium-citrate co-transporter (SLC13A5) inhibitor. SLC13A5-IN-1 completely blocksthe uptake of14C-citrate with an IC50 value of 0.022 μM in HepG2 cells. SLC13A5-IN-1 has the potential for the treatment of metabolic and/or cardiovascular diseases. SLC13A5-IN-1 is extracted from patent WO2018104220A1, Compound I-5[1].

References

[1] Joerg Kley, et al. Sulfonamides as inhibitors of the uptake of extracellular citrate. Patent WO2018104220A1

SLC13A5-IN-1 Preparation Products And Raw materials

Raw materials

Preparation Products

SLC13A5-IN-1 Suppliers

Global Suppliers ( 26)
Supplier Tel Email Country ProdList Advantage
Shanghai YuanYe Biotechnology Co., Ltd. 15026964105 2881489226@qq.com China 89667 60
Tianjin Kailiqi Biotechnology Co., Ltd. 15076683720 klq@cw-bio.com China 9786 55
ShangHai Biochempartner Co.,Ltd 177-54423994 17754423994 2853530910@QQ.com China 8000 62
Angel Pharmatech, Ltd. 17317130613 3358272972@qq.com China 3307 58
TargetMol Chemicals Inc. +1-781-999-5354; +1-00000000000 marketing@targetmol.com United States 32431 58
Shandong Jirun Biomedical Technology Co., Ltd. 0539-0539-8613587 17661611089 2639273505@qq.com China 237 58
Zhejiang Huida Biotech Co., LTD 0571-89903022 18679456698 zilong@hizyme.com China 8001 58
Jinan Jiuli Biotechnology Co. , Ltd. 15865264761 486064515@qq.com China 4999 58
Beijing Jin Ming Biotechnology Co., Ltd. 010-60605840 psaitong@jm-bio.com China 27626 58
Bide Pharmatech Ltd. 400-1647117 13681763483 product02@bidepharm.com China 59929 58

View Latest Price from SLC13A5-IN-1 manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
SLC13A5-IN-1 pictures 2026-09-10 SLC13A5-IN-1
2227548-95-8
$98.00-297.00 99.67% 10g TargetMol Chemicals Inc.
SLC13A5-IN-1 pictures 2026-07-14 SLC13A5-IN-1
2227548-95-8
$98.00-297.00 99.67% 10g TargetMol Chemicals Inc.
  • SLC13A5-IN-1 pictures
  • SLC13A5-IN-1
    2227548-95-8
  • $98.00-297.00
  • 99.67%
  • TargetMol Chemicals Inc.
  • SLC13A5-IN-1 pictures
  • SLC13A5-IN-1
    2227548-95-8
  • $98.00-297.00
  • 99.67%
  • TargetMol Chemicals Inc.

SLC13A5-IN-1 Spectrum

SLC13A5-IN-1 N-[(4-chlorophenyl)methyl]-1-(3,5-dichlorobenzen esulfonyl)piperidine-4-carboxamide 4-Piperidinecarboxamide, N-[(4-chlorophenyl)methyl]-1-[(3,5-dichlorophenyl)sulfonyl]- hSLC3A5,metabolic,SLC-13A5-IN-1,SLC13A5IN1,Inhibitor,Citrate,SLC13A5,cardiovascular,inhibit,disease,Sodium Channel,Uptake,Na channels,Na+ channels,SLC13A5 IN 1 N-(4-Chlorobenzyl)-1-((3,5-dichlorophenyl)sulfonyl)piperidine-4-carboxamide SLC13A5-IN-1, 10 mM in DMSO 2227548-95-8